Provided by Tiger Trade Technology Pte. Ltd.

Karyopharm Therapeutics

1.43
-0.1900-11.73%
Volume:5.11M
Turnover:7.16M
Market Cap:32.41M
PE:-0.11
High:1.61
Open:1.50
Low:1.24
Close:1.62
52wk High:10.99
52wk Low:1.24
Shares:22.66M
Float Shares:15.77M
Volume Ratio:13.11
T/O Rate:32.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-13.0816
EPS(LYR):-17.9300
ROE:-891.05%
ROA:-47.61%
PB:-0.10
PE(LYR):-0.08

Loading ...

Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Dec 13, 2023

Major Issues Report

Form 8-K - Current report
Dec 08, 2023

Major Issues Report

Form 8-K - Current report
Nov 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2023

Major Issues Report

Form 8-K - Current report
Sep 01, 2023

Major Issues Report

Form 8-K - Current report
Aug 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 02, 2023

Major Issues Report

Form 8-K - Current report
Aug 02, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 25, 2023

Major Issues Report

Form 8-K - Current report
May 04, 2023

Major Issues Report

8-K - Current report
May 04, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 03, 2023

Correspondence

Form CORRESP - Correspondence
Mar 10, 2023

Major Issues Report

8-K - Current report
Feb 17, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 17, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]